Rep. Gilbert Ray Cisneros, Jr. Buys The Cooper Companies, Inc. (NASDAQ:COO) Stock

Representative Gilbert Ray Cisneros, Jr. (Democratic-California) recently bought shares of The Cooper Companies, Inc. (NASDAQ:COO). In a filing disclosed on June 08th, the Representative disclosed that they had bought between $1,001 and $15,000 in Cooper Companies stock on May 29th. The trade occurred in the Representative’s “150 MAIN STREET TRUST > BANK OF AMERICA” account.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

• Purchased $1,001 – $15,000 in shares of SoftBank Group (OTCMKTS:SFTBF) on 6/2/2026.
• Purchased $1,001 – $15,000 in shares of Ciena (NYSE:CIEN) on 5/29/2026.
• Sold $1,001 – $15,000 in shares of AutoZone (NYSE:AZO) on 5/29/2026.
• Purchased $1,001 – $15,000 in shares of Independent Bank (NASDAQ:INDB) on 5/29/2026.
• Purchased $1,001 – $15,000 in shares of Arcutis Biotherapeutics (NASDAQ:ARQT) on 5/29/2026.
• Purchased $1,001 – $15,000 in shares of HealthEquity (NASDAQ:HQY) on 5/29/2026.
• Purchased $1,001 – $15,000 in shares of Boston Scientific (NYSE:BSX) on 5/29/2026.
• Purchased $1,001 – $15,000 in shares of Perella Weinberg Partners (NASDAQ:PWP) on 5/29/2026.
• Purchased $1,001 – $15,000 in shares of Ligand Pharmaceuticals (NASDAQ:LGND) on 5/29/2026.
• Sold $15,001 – $50,000 in shares of Workday (NASDAQ:WDAY) on 5/29/2026.

Cooper Companies Price Performance

Shares of NASDAQ:COO traded down $0.92 during trading on Wednesday, reaching $67.70. The stock had a trading volume of 3,013,405 shares, compared to its average volume of 2,362,051. The Cooper Companies, Inc. has a 52 week low of $58.89 and a 52 week high of $89.83. The business’s 50-day moving average price is $64.97 and its 200 day moving average price is $74.48. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.27 and a quick ratio of 0.78. The stock has a market capitalization of $13.20 billion, a PE ratio of 57.37, a P/E/G ratio of 1.75 and a beta of 0.87.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.10 by $0.11. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The company had revenue of $1.08 billion during the quarter, compared to analysts’ expectations of $1.05 billion. During the same quarter in the previous year, the company posted $0.96 earnings per share. Cooper Companies’s quarterly revenue was up 7.9% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. As a group, equities analysts predict that The Cooper Companies, Inc. will post 4.63 earnings per share for the current year.

Trending Headlines about Cooper Companies

Here are the key news stories impacting Cooper Companies this week:

• Positive Sentiment: Several recent analyst write-ups remain constructive on Cooper Companies, highlighting solid demand growth, a prior quarterly earnings beat, and the possibility of a future rating upgrade as valuation becomes more attractive. The Cooper Companies: I Can See A Potential Upgrade On The Horizon
• Positive Sentiment: Another bullish note pointed to Cooper Companies as a long-term growth stock, suggesting investors may continue to focus on its underlying business momentum. Why The Cooper Companies (COO) is a Top Growth Stock for the Long-Term
• Neutral Sentiment: A separate article noted that short interest data showed no meaningful change in the latest update, so it does not appear to be a major driver for the stock right now.
• Negative Sentiment: An SEC filing showed an insider sold about $828,000 of stock, which can weigh on sentiment even if the sale is routine or personal in nature. COO Sells $828K Worth of AMR Stock, According to Recent SEC Filing
• Negative Sentiment: Some commentary remained cautious on profitability, pointing to litigation-related charges, mixed margins, and the need for stronger return on equity, which may be tempering enthusiasm for the shares.

Wall Street Analyst Weigh In

COO has been the subject of a number of research analyst reports. Mizuho set a $85.00 target price on shares of Cooper Companies and gave the company an “outperform” rating in a research note on Thursday, June 4th. BNP Paribas Exane cut their target price on shares of Cooper Companies from $95.00 to $92.00 and set an “outperform” rating for the company in a research note on Monday. KeyCorp reiterated a “sector weight” rating on shares of Cooper Companies in a research note on Friday, June 5th. Needham & Company LLC dropped their price objective on shares of Cooper Companies from $101.00 to $86.00 and set a “buy” rating for the company in a research report on Friday, June 5th. Finally, Robert W. Baird dropped their price objective on shares of Cooper Companies from $98.00 to $85.00 and set an “outperform” rating for the company in a research report on Friday, June 5th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, five have assigned a Hold rating and three have issued a Sell rating to the company’s stock. According to data from MarketBeat, Cooper Companies currently has an average rating of “Hold” and an average target price of $82.64.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of COO. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in Cooper Companies by 48.9% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 22,407 shares of the medical device company’s stock worth $1,890,000 after purchasing an additional 7,363 shares during the last quarter. First Trust Advisors LP raised its position in Cooper Companies by 115.8% in the 2nd quarter. First Trust Advisors LP now owns 136,334 shares of the medical device company’s stock worth $9,702,000 after purchasing an additional 73,165 shares during the last quarter. Cresset Asset Management LLC bought a new stake in shares of Cooper Companies during the 2nd quarter valued at $291,000. Cerity Partners LLC raised its position in shares of Cooper Companies by 4.4% during the 2nd quarter. Cerity Partners LLC now owns 17,870 shares of the medical device company’s stock valued at $1,272,000 after acquiring an additional 757 shares during the last quarter. Finally, Daiwa Securities Group Inc. raised its position in shares of Cooper Companies by 2.8% during the 2nd quarter. Daiwa Securities Group Inc. now owns 35,839 shares of the medical device company’s stock valued at $2,551,000 after acquiring an additional 973 shares during the last quarter. Institutional investors own 24.39% of the company’s stock.

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California’s 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California’s 31st Congressional District. He declared candidacy for the 2026 election.

Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor’s degree in political science from George Washington University in 1994, a master’s in business administration from Regis University in 2002, and a master’s degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.